Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

Part of paid clinical trials in Sacramento, California.

Sponsor
Integrative Skin Science and Research
Study ID
NCT07544251
Phase
PHASE4
Status
Recruiting

Conditions

  • Acne Vulgaris

Eligibility Criteria

Sex
ALL
Age
9 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Sarecycline — DRUG
    One tablet by mouth (weight based dosing at 1.5 mg/kg and rounded to the closest tablet dose at either 60 mg, 100mg, or 150 mg tablet) once a day with food and a full glass of water (about 8 ounces)
  • Doxycycline — DRUG
    100 mg twice daily with food and a full glass of water (about 8 ounces)

Study Details

This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile of the bacteria that is present.

Key Dates

Start date
Apr 20, 2026
Status verified
Apr 2026
Primary completion
Apr 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Sarecycline Group
    Half of the participants will be randomized to receive sarecycline treatment.
  • Experimental: Doxycycline Group
    Half of the participants will be randomized to receive doxycycline treatment.

Primary Outcome Measure

Change in the relative abundance of tetracycline-resistant bacteria in the gut microbiome [ Time Frame: From enrollment to the end of treatment at 4 weeks. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Integrative Research InstituteSacramentoCalifornia95819
Nasima Afzal Chief Operating Officer
209-607-8778

Find similar trials in Sacramento, CA

Related Studies